5-hydroxytryptamine-receptor antagonists versus prochlorperazine for control of delayed nausea caused by doxorubicin: a URCC CCOP randomised controlled trial
Author:
Jane T Hickok,Joseph A Roscoe,Gary R Morrow,Christopher W Bole,Hongwei Zhao,Karen L Hoelzer,Shaker R Dakhil,Timothy Moore,Tom R Fitch
Publication:
The Lancet Oncology
Copyright © 2005 Elsevier Ltd. All rights reserved.